Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma

Clinical trial NCT06864221 · RECRUITING

Trial details

NCT number: NCT06864221
Sponsor: Nanfang Hospital, Southern Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Radiotherapy Treatment Outcome Biomarkers Sphingolipids

Start date: 2024-09-01
Primary completion: 2026-01-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.